The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients
Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Carlo Maurea(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesca Izzo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), I Giacobbe(University of Campania "Luigi Vanvitelli"), Domenico Gabrielli(Azienda Ospedaliera San Camillo-Forlanini), Massimiliano Berretta(University of Messina), Andrea Paccone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandro Inno(Ospedale Sacro Cuore Don Calabria), Matteo Barbato(University of Milan), Martina Iovine(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Marino Scherillo, Maria Laura Canale(Ospedale Versilia), Vienna Giordano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Raffaele Arianna(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Irma Bisceglia(Azienda Ospedaliera San Camillo-Forlanini)
Cited by 14
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
|Critical Reviews in Oncology/Hematology|2019|164
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105